Goldman Sachs’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Buy
1,070,517
+149,313
+16% +$217K ﹤0.01% 4687
2025
Q4
$1.06M Buy
921,204
+861,857
+1,452% +$1.18M ﹤0.01% 5097
2025
Q3
$80.1K Sell
59,347
-266,399
-82% -$302K ﹤0.01% 6114
2025
Q2
$308K Sell
325,746
-29,406
-8% -$19.1K ﹤0.01% 5433
2025
Q1
$164K Sell
355,152
-185,055
-34% -$117K ﹤0.01% 5677
2024
Q4
$399K Buy
540,207
+138,916
+35% +$167K ﹤0.01% 5362
2024
Q3
$630K Buy
401,291
+27,860
+7% +$49.6K ﹤0.01% 4920
2024
Q2
$627K Buy
373,431
+217,217
+139% +$390K ﹤0.01% 4700
2024
Q1
$375K Sell
156,214
-79,125
-34% -$170K ﹤0.01% 4877
2023
Q4
$360K Sell
235,339
-124,372
-35% -$148K ﹤0.01% 4911
2023
Q3
$392K Sell
359,711
-193,297
-35% -$339K ﹤0.01% 4759
2023
Q2
$1.27M Buy
553,008
+264,070
+91% +$701K ﹤0.01% 4188
2023
Q1
$702K Buy
288,938
+22,581
+8% +$51.7K ﹤0.01% 4626
2022
Q4
$509K Buy
266,357
+25,436
+11% +$54.1K ﹤0.01% 4855
2022
Q3
$578K Buy
240,921
+32,896
+16% +$91K ﹤0.01% 4876
2022
Q2
$387K Buy
208,025
+25,354
+14% +$48.4K ﹤0.01% 5261
2022
Q1
$381K Buy
182,671
+25,189
+16% +$69.8K ﹤0.01% 5509
2021
Q4
$621K Buy
157,482
+67,569
+75% +$328K ﹤0.01% 5223
2021
Q3
$432K Buy
89,913
+18,925
+27% +$77.7K ﹤0.01% 5280
2021
Q2
$326K Buy
70,988
+5,929
+9% +$28.6K ﹤0.01% 5473
2021
Q1
$382K Sell
65,059
-8,297
-11% -$57.5K ﹤0.01% 5295
2020
Q4
$250K Sell
73,356
-68,139
-48% -$130K ﹤0.01% 4976
2020
Q3
$203K Sell
141,495
-374,647
-73% -$667K ﹤0.01% 4907
2020
Q2
$1.03M Buy
516,142
+314,823
+156% +$617K ﹤0.01% 3926
2020
Q1
$392K Buy
201,319
+56,927
+39% +$169K ﹤0.01% 4353
2019
Q4
$599K Sell
144,392
-39,720
-22% -$153K ﹤0.01% 4402
2019
Q3
$554K Buy
184,112
+66,801
+57% +$207K ﹤0.01% 4397
2019
Q2
$738K Buy
117,311
+1,412
+1% +$8.45K ﹤0.01% 4178
2019
Q1
$644K Buy
115,899
+10,806
+10% +$65.6K ﹤0.01% 4288
2018
Q4
$698K Sell
105,093
-4,565
-4% -$37K ﹤0.01% 4183
2018
Q3
$1.17M Sell
109,658
-5,730
-5% -$65.7K ﹤0.01% 3948
2018
Q2
$1.39M Buy
115,388
+47,899
+71% +$490K ﹤0.01% 3866
2018
Q1
$578K Sell
67,489
-66,753
-50% -$617K ﹤0.01% 4400
2017
Q4
$1.33M Sell
134,242
-110,094
-45% -$1.14M ﹤0.01% 4119
2017
Q3
$3M Buy
244,336
+110,293
+82% +$1.63M ﹤0.01% 3616
2017
Q2
$2.21M Buy
134,043
+20,379
+18% +$316K ﹤0.01% 3764
2017
Q1
$1.63M Sell
113,664
-56,244
-33% -$834K ﹤0.01% 3948
2016
Q4
$2.35M Buy
169,908
+46,581
+38% +$747K ﹤0.01% 3702
2016
Q3
$2.23M Buy
123,327
+40,317
+49% +$649K ﹤0.01% 3735
2016
Q2
$1.19M Sell
83,010
-104,826
-56% -$1.42M ﹤0.01% 4052
2016
Q1
$2.25M Buy
187,836
+75,360
+67% +$790K ﹤0.01% 3365
2015
Q4
$1.5M Sell
112,476
-420,929
-79% -$5.18M ﹤0.01% 3899
2015
Q3
$5.73M Buy
533,405
+511,904
+2,381% +$5.59M ﹤0.01% 2766
2015
Q2
$173K Sell
21,501
-6,057
-22% -$44.5K ﹤0.01% 6257
2015
Q1
$182K Sell
27,558
-22,004
-44% -$150K ﹤0.01% 6083
2014
Q4
$316K Buy
49,562
+37,297
+304% +$301K ﹤0.01% 5728
2014
Q3
$121K Buy
12,265
+164
+1% +$1.75K ﹤0.01% 6493
2014
Q2
$136K Buy
12,101
+1,841
+18% +$19.8K ﹤0.01% 6427
2014
Q1
$124K Sell
10,260
-21,086
-67% -$269K ﹤0.01% 6318
2013
Q4
$395K Sell
31,346
-6,923
-18% -$110K ﹤0.01% 5478
2013
Q3
$637K Buy
38,269
+26,189
+217% +$439K ﹤0.01% 4970
2013
Q2
$183K Buy
+12,080
New +$184K ﹤0.01% 5646

Other funds holding LXRX